A DNA vaccine as a prophylaxis for hepatitis C virus (HCV) infection. HCV specific CTL induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model.

被引:0
|
作者
Arichi, T
Saito, T
Major, ME
Shirai, M
Engelhard, VH
Feinstone, SM
Berzofsky, JA
机构
[1] NCI, NIH, Bethesda, MD 20892 USA
[2] US FDA, Bethesda, MD 20014 USA
[3] Univ Virginia, Charlottesville, VA USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
994
引用
收藏
页码:409A / 409A
页数:1
相关论文
共 31 条
  • [21] Phase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) Infection
    Jacobson, Jeffrey M.
    Zahrieh, David
    Strand, Carrie A.
    Cruz-Correa, Marcia
    Pungpapong, Surakit
    Roberts, Lewis R.
    Mandrekar, Sumithra J.
    Rodriguez, Luz Maria
    Boyer, Jean
    Marrero, Idania
    Kraynyak, Kimberly A.
    Morrow, Matthew P.
    Sylvester, Albert J.
    Pawlicki, Jan M.
    Gillespie, Elisabeth
    Barranco, Eduardo
    Richmond, Ellen
    Umar, Asad
    Weiner, David B.
    Limburg, Paul J.
    Cancer Prevention Network
    [J]. CANCER PREVENTION RESEARCH, 2023, 16 (03) : 163 - 174
  • [22] Recombinant adenoviral vector expressing HCV NS4 induces protective immune responses in a mouse model of Vaccinia-HCV virus infection: A dose and route conundrum
    Singh, Shakti
    Vedi, Satish
    Li, Wen
    Samrat, Subodh Kumar
    Kumar, Rakesh
    Agrawal, Babita
    [J]. VACCINE, 2014, 32 (23) : 2712 - 2721
  • [23] Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection
    Quiroga, Juan A.
    Llorente, Silvia
    Castillo, Inmaculada
    Rodriguez-Inigo, Elena
    Lopez-Alcorocho, Juan Manuel
    Pardo, Margarita
    Carreno, Vicente
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2006, 78 (09) : 1190 - 1197
  • [24] Impact of HCV specific CD4+ T cell responses and hepatitis C viral kinetics on the outcome and progression of acute hepatitis C virus infection.
    Kamal, SM
    Graham, C
    He, Q
    Rasenack, J
    Bianchi, L
    Koziel, M
    [J]. HEPATOLOGY, 2002, 36 (04) : 314A - 314A
  • [25] DNA vaccine expressing the non-structural proteins of hepatitis C virus diminishes the expression of HCV proteins in a mouse model
    Wada, Takeshi
    Kohara, Michinori
    Yasutomi, Yasuhiro
    [J]. VACCINE, 2013, 31 (50) : 5968 - 5974
  • [26] Blocking of IL-10 receptor - A novel approach to stimulate virus-specific T cell reactivity in chronic hepatitis C virus (HCV) infection.
    Rigopoulou, EI
    Abbott, WG
    Willams, R
    Lan, JYN
    Naoumov, NV
    [J]. HEPATOLOGY, 2000, 32 (04) : 304A - 304A
  • [27] Chronic alcohol consumption inhibits the CTL response against hepatitis C virus (HCV) NS5 protein following DNA based immunization in a syngeneic tumor model.
    Ince, N
    Tamaki, S
    Cousens, L
    Wands, JR
    [J]. HEPATOLOGY, 2000, 32 (04) : 222A - 222A
  • [28] Hepatitis C virus (HCV)-specific T cell confer resistance to HCV re-infection after sustained virologic response in a non-cytolytic fashion among people who inject drugs: results from ANCHOR study
    Khanam, Arshi
    Ghosh, Alip
    Kattakuzhy, Sarah
    Kottilil, Shyamasundaran
    Rosenthal, Elana
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 : S571 - S571
  • [29] Switching from CNI-based immune suppression to Sirolimus improves survival after liver transplantation in patients with Hepatitis C virus (HCV) infection. A single centre, 15-year experience
    Shah, Meera
    Shankar, Arun N.
    Gee, Ian
    Nash, Kathryn L.
    Hoare, Matthew
    Gibbs, Paul
    Alexander, Graeme J.
    [J]. HEPATOLOGY, 2013, 58 : 1019A - 1019A
  • [30] High resolution in situ analysis of CD8 T cells infiltrating the liver during chronic hepatitis C virus infection:: HCV-specific cells protect from progression to severe disease
    Abel, M
    Sene, D
    Pol, S
    Bourlière, M
    Poynard, T
    Charlotte, F
    Caillat-Zucman, S
    Cacoub, P
    [J]. HEPATOLOGY, 2005, 42 (04) : 245A - 245A